ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Nucala 100 mg/mL, Injektionslösung in der Fertigspritze - 
67351001 GlaxoSmithKline AG
Nucala 100 mg/mL, Injektionslösung in der Fertigspritze13.02.2020
  13.02.2020
(R03DX09) 
WHO-DDD 
03.04.50. 
03.04.50. 
B  
Yes 
IPCI
976.63Yes
    
10 %1078.55
  
7680673510018Biotechnologika
7769442 
Composition
mepolizumabum 100 mg, saccharum, dinatrii phosphas heptahydricus, acidum citricum monohydricum, polysorbatum 80 dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.0 ml.
Packungsbestandteile
  
  
 
Active AgentDose
 100mg / 1ml
BAG: Active AgentDose
 100 mg
 
Inactive agents
Citric Acid Monohydrate
Disodium Phosphate Heptahydrate
 
Saccharum
 
Source
Data was imported : 04.10.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home